Clofoctol

This classification denotes an anti-infective agent with the molecular formula C21H26Cl2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 704083NI0R, chemically known as 2-((2,4-dichlorophenyl)methyl)-4-(1,1,3,3-tetramethylbutyl)phenol but generally known as clofoctol, which bears US NIH Compound Identifier 2799. European Medicines Agency schedules Clofoctol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06711MIG. The term CLOFOCTOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules clofoctol in its Anatomical Therapeutic Chemical (ATC) Classification. CLOFOCTOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clofoctol under HS 29081900 and SITC 51244. As of Q4 2014, CLOFOCTOL remains the US FDA Preferred Term for this commodity. Clofoctol bears US NLM identifiers UMLS ID C0055915 and NCI Concept Code C78048. SMILES: CLC1C(CC2CC(C(CC(C)(C)C)(C)C)CCC2O)CCC(CL)C1.